IL-38 Evaluation as a Biomarker in Pediatric Asthma

Cairo University103 enrolled

Overview

The aim of this study is to investigate the associations between serum IL-38 levels and different variables of asthma in children such as laboratory variables, pulmonary function test results, the diagnosis of asthma, and in correlation with disease severity.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

103

Conditions

Bronchial Asthma

Interventions

Il-38 serum levelDIAGNOSTIC_TEST

measurement of serum levels of IL-38

Eligibility

Sex: ALLMin age: 6 YearsMax age: 14 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * patients fulfilled the criteria of the Global Initiative for Asthma (GINA) * Age group:6-14 years Exclusion Criteria: * Malignancy * Chronic inflammatory diseases

Locations (1)

Asmaa Kamal

Cairo, Egypt

Outcomes

Primary Outcomes

serum IL-38 levels

Measurement of Interleukin 38 in sera of all study subjects by ELISA

Time frame: within 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.